Emergent BioSolutions’ ACAM2000 receives FDA approval for Mpox prevention
Emergent BioSolutions Inc. (NYSE: EBS) has achieved a notable milestone with the U.S. Food and Drug Administration (FDA) approving the supplemental Biologics License Application (sBLA) ... Read More
Shocking Mpox surge: Over 15,000 cases in Africa—WHO sounds alarm
Africa is facing a significant health crisis as the mpox outbreak has surged, prompting the World Health Organization (WHO) to convene an urgent meeting to ... Read More